PAM
PROK icon

Panagora Asset Management’s ProKidney PROK Stock Holding History

Panagora Asset Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,572
Closed -$87K – 2232
2021
Q2 		$87K Buy
+8,572
New +$86.7K ﹤0.01% 1940

Other funds holding PROK

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Panagora Asset Management's PROK Position: Q3 2021 in Review

Panagora Asset Management sold out of ProKidney (PROK) in Q3 2021, closing a stake of 8,572 shares — an estimated $87K sold.

Panagora Asset Management first reported a position in PROK in Q2 2021 and held it in 1 quarter. The position peaked at $87K in Q2 2021. 84 funds tracked by Wall St. Rank hold PROK as of Q3 2021.

  • Panagora Asset Management reported no remaining ProKidney position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 8,572 ProKidney shares in Q3 2021, an estimated $87K.
  • Panagora Asset Management first reported a position in ProKidney in Q2 2021 and held it in 1 quarter.
  • Panagora Asset Management's ProKidney position peaked at $87K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held ProKidney as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.